SEATTLE'S SWEDISH CANCER INSTITUTE FIRST IN U.S. TO TREAT CANCER PATIENT WITH ELEKTA VMAT

SEATTLE'S SWEDISH CANCER INSTITUTE FIRST IN U.S. TO TREAT CANCER PATIENT WITH
ELEKTA VMAT

Press Release 
Seattle, WA and Atlanta, GA - July 30, 2008

A patient with pancreatic cancer recently became the first person in the United
States to receive treatment using Elekta VMAT (Volumetric intensity Modulated
Arc Therapy) at Seattle's Swedish Cancer Institute. This revolutionary new
technology dramatically decreases treatment times - delivering a higher dose to
the tumor target without compromising coverage and patient safety.

From the patient's perspective, faster treatment times often mean improved
comfort, which makes it easier to remain still during treatment and increases
the likelihood of delivering radiation beams more accurately and safely. From
the physician's perspective, the reduction in treatment time makes it much
easier to accurately target the tumor and the improved dose sparing offers new
options to either increase the cancer-killing dose to a tumor or reduce side
effects and therefore potentially improve outcomes. 

David Shepard, director of Medical Physics at Swedish Cancer Institute, says,
“The use of Elekta VMAT allowed us to reduce our patient's delivery time by
half, relative to a conventional IMRT delivery. The total treatment time was
less than 10 minutes, including Cone Beam CT image guidance. More importantly,
we were able to reduce the dose to surrounding sensitive structures such as the
spinal cord, left and right kidneys and the liver.”

Shepard is presenting his work on VMAT at the Elekta VMAT Consortium meeting
during the 2008 American Association of Physicists in Medicine (AAPM) annual
meeting along with other U.S. and international hospitals who have either
started or plan to start a VMAT clinical program.

Vivek Mehta, M.D., director of the Center for Advanced Targeted Radiation
Therapies at the Swedish Cancer Institute, emphasizes, “VMAT technology will
enable us to design treatment approaches that are more aggressive in killing
cancer cells and have fewer side effects.”

Dr. Mehta says the implementation of Elekta VMAT at Swedish Cancer Institute has
advanced the program's overall mission. “By introducing VMAT technology today,
we have continued to build on the Swedish Cancer Institute's rich tradition of
innovation in cancer care. We were among the first to begin using Image Guided
Radiation Therapy (IGRT) utilizing cone Beam CT technology to improve setup
accuracy and treatment precision, and now we've begun treating with VMAT. As the
largest and most comprehensive cancer treatment program in the Pacific
Northwest, improving patient care is our mission and we work daily to make that
a reality.”

Elekta VMAT
The speed and precision of Elekta VMAT is made possible by simultaneous
manipulation of the gantry position and gantry speed, the multileaf collimator
leaves, the dose rate and the collimator angle, all while the radiation beam is
on. In addition, Elekta VMAT allows the flexibility of one arc, two arcs,
sub-arc or a combination. 

To ensure the accuracy of this highly conformal treatment, Elekta VMAT uses
daily ultra low dose 3D volumetric imaging via Elekta VolumeView™. VolumeView
imaging is accomplished in under two minutes, complementing the speed of
treatments. For additional information, visit www.elekta.com/vmat.

******






For further information, please contact:

Michelle Lee, PR and Advertising Manager
Tel: +1 770-670-2447, e-mail: michelle.lee@elekta.com

Peter Ejemyr, Vice President Global Marketing.
Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com  

About Elekta

Elekta is an international medical technology group, providing oncologists,
radiation therapists, neurosurgeons and many other medical specialists with
state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and
information systems as well as services for improved cancer care and management
of brain disorders. 

Elekta's systems and solutions are used in over 5,000 hospitals around the
world. Clinical and information management solutions include, among others,
Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta
Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy
and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR
and efficient management of clinical and patient data.

With around 2,500 employees globally, the corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. More information about Elekta can be found at www.elekta.com.

About the Swedish Cancer Institute

The Swedish Cancer Institute (SCI) opened in 1932 as the first dedicated
cancer-care center west of the Mississippi. Now in its 75th year, it is the
largest and most comprehensive cancer treatment program in the Pacific
Northwest. A true multidisciplinary program, SCI offers a wide range of advanced
cancer-treatment options in chemotherapy, radiation therapy and surgery - backed
by extensive diagnostic capabilities, patient education and support-group
services. SCI's clinical-research arm encompasses industry-sponsored and
cooperative group therapeutic trials, cancer screening and prevention trials,
and investigator-initiated trials. Breast-cancer screening and diagnostics are
available through the Swedish Breast Care Centers and mobile mammography units.
For more information, visit www.swedish.org

About the Center for Advanced Targeted Radiation Therapies

The Swedish Cancer Institute's Center for Advanced Targeted Radiation Therapies
encompasses the comprehensive and complimentary array of advanced and emerging
radiation delivery tools available to patients for both approved therapies and
clinical research efforts. They include a variety of technologies, including
Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy
(IGRT), linear accelerator-based stereotactic radio surgery, Calypso® 4D
Localization System, Xoft Axxent™ Electronic Brachytherapy System, MammoSite®
Radiation Therapy System, the Seattle CyberKnife Center™ at Swedish Medical
Center, and Northwest Hospital Gamma Knife Center. SCI is also working toward
adding the latest generation of proton beam radiotherapy systems to this arsenal
of cancer-fighting tools by December 2010.